[Image from the Abbott website] Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent ... at SSM Health Heart & Vascular Care ...

Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral artery disease (PAD). The data, which was presented as a late ...

Esprit BTK was approved by the FDA in April. Image credit: Shutterstock / Sundry Photography. Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most ...

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease located below the knee, following the implant’s approval by the FDA ...

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first patient procedures with a yet-unnamed transcatheter aortic valve ...

A coronary stent is an expandable metal mesh coil that helps open an artery that supplies the heart with blood. It’s used to prevent a heart attack or help improve survival after one occurs.

11, 2024 (HealthDay News) -- Recurring angina chest pain in people with a certain type of heart disease can be tough to treat, but a new hourglass-shaped stent could be a real advance, researchers ...